Mater Misericordiae University Hospital   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Dublin Ireland (1861)

Organization Overview

First Clinical Trial
2009
NCT00981773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Mater Misericordiae University Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Bone Demineralization, Pathologic (Phase 4)

Cellulitis (Phase 4)

Emergencies (Phase 4)

Hepatitis C (Phase 4)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Multiple Myeloma (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Wound Infection (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 21